CSBTF fundamentals
Kuros Bioscience Ltd. financial statements, including revenue, expenses, and profit
The total revenue of CSBTF for the last semiannual is 48.13 M USD, and it's 35.88% higher compared to the previous semiannual. The net income of H2 24 is -4.49 M USD.
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
TTM